Society for maternal and fetal medicine workshop on pregnancy as a window to future health: Clinical utility of classifying women with metabolic syndrome

Seminars in Perinatology

Volumn 39, Issue 4, 2015, Pages 284-289

  Carson, Michael P ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes; Hyperlipidemia; Hypertension; Metabolic syndrome; Obesity; Pregnancy

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; URINARY EXCRETION; WORKSHOP; ADULT; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; EDUCATION; EPIDEMIOLOGY; FEMALE; INFLAMMATION; MATERNAL CHILD HEALTH CARE; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVENTION AND CONTROL; PRIMARY PREVENTION; RISK REDUCTION; SMOKING; UNITED STATES; WOMEN'S HEALTH;

ADULT; CARDIOVASCULAR DISEASES; DIABETES, GESTATIONAL; EARLY DIAGNOSIS; FEMALE; HUMANS; INFLAMMATION; MATERNAL-CHILD HEALTH SERVICES; METABOLIC SYNDROME X; OBESITY; PREGNANCY; PRIMARY PREVENTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SOCIETIES, MEDICAL; UNITED STATES; WOMEN'S HEALTH;

EID: 84937970023     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2015.05.007     Document Type: Review

References (27)

1. Carson M.P., Frank M.I., Keely E. Original research: postpartum testing rates among women with a history of gestational diabetes-systematic review. Prim care diabetes 2013, 7(3):177-186.
2. Savitz D.A., Danilack V.A., Elston B., Lipkind H.S. Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am J Epidemiol 2014, 180(1):41-44.
3. Murphy S.L., Xu J., Kochanek K.D. Deaths: final data for 2010. Natl Vital Stat Rep 2013, 61(4):1-118.
4. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37(12):1595-1607.
5. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109(3):433-438.
6. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992, 20(suppl 8):S5-S10.
7. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752.
8. International Diabetes Foundation. The IDF consensus worldwide definition of the metabolic syndrome. 〈〉; 2006 Accessed 30.06.14. http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf.
9. Balkau B., Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999, 16(5):442-443.
10. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005, 28(11):2745-2749.
11. Adams R.J., Appleton S., Wilson D.H., et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005, 28(11):2777-2779.
12. Lawlor D.A., Smith G.D., Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006, 49(1):41-48.
13. Meigs J.B., Rutter M.K., Sullivan L.M., Fox C.S., D'Agostino R.B., Wilson P.W. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007, 30(5):1219-1225.
14. Adams ST, Leveson SH. Clinical prediction rules. BMJ 2012;344:d8312, http://dx.doi.org/10.1136/bmj.d8312.
15. Van Staa T.P., Setakis E., Di Tanna G.L., Lane D.A., Lip G.Y. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. Thromb Haemost 2011, 9(1):39-48.
16. Cameron A.J., Magliano D.J., Zimmet P.Z., et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med 2008, 264(2):177-186.
17. Saely C.H., Koch L., Schmid F., et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006, 29(4):901-907.
18. Wannamethee S.G., Shaper A.G., Lennon L., Morris R.W. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005, 165(22):2644-2650.
19. Sattar N., McConnachie A., Shaper A.G., et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008, 371(9628):1927-1935.
20. Meigs JB. The metabolic syndrome (insulin resistance syndrome or syndrome X). In: UpToDate, Post TW (Ed). UpToDate: Waltham, MA; (Accessed on November 25, 2014).
21. Rosenzweig J.L., Ferrannini E., Grundy S.M., et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93(10):3671-3689.
22. International Expert Committee Report on the Role of the A1C Assay in the diagnosis of diabetes. Diabetes Care 2009, 32(7):1327-1334.
23. Carson M., Lewis B., Pagan E., Evers M. Evaluation of home testing to improve follow up after gestational diabetes (Fingerstick Assessments of Sugar Two-months postpartum or FAST). Obstet Med 2013, 6(3):120-124.
24. Bennett W.L., Ennen C.S., Carrese J.A., et al. Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study. J Womens Health (Larchmt) 2011, 20(2):239-245.
25. Carson M.P., Morgan B., Gussman D., Brown M., Rothenberg K., Wisner T.A. SUGAR: spotting undiagnosed glucose abnormalities: a new protocol to increase postpartum testing among women with gestational diabetes mellitus. Am J Perinatol 2015, 32(3):299-306.
26. Committee on Obstetric Practice ACOG Committee Opinion No. 435: postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009, 113(6):1419-1421.
27. American Diabetes Association Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(suppl 1):S11-S63.